why am i gaining weight on semaglutide compound The Pros and Cons of for Loss Semaglutide Cost Per Month —

Now, some compounded versions that were once permitted may be violative

Summary: Retatrutide is an investigational triple hormone receptor agonist peptide (GLP-1, GIP, and glucagon) developed by Eli Lilly for obesity treatment, currently in Phase 3 trials and not yet approved by the MHRA or EMA

This guide explains what retatrutide is, how its triple-receptor mechanism works, who it is being studied for, the trial results and side effects reported so far, how it compares to semaglutide and tirzepatide, and where it stands in the FDA approval process

Additionally, your doctor might explore transitioning you to more cost-effective oral medications, such as metformin or naltrexone/bupropion, to help you maintain your progress after tapering off completely

Treatment plans are individualized, and long-term use is determined by a medical practitioner based on health goals and progress